Brokerages Set Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) PT at $27.50

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) has earned an average rating of "Moderate Buy" from the six brokerages that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $27.50.

KMTS has been the subject of several research reports. Stifel Nicolaus assumed coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They issued a "buy" rating and a $28.00 target price for the company. Piper Sandler assumed coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set an "overweight" rating and a $27.00 price objective for the company. Wells Fargo & Company assumed coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set an "overweight" rating and a $28.00 price objective for the company. Bank of America assumed coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set a "buy" rating and a $30.00 price objective for the company. Finally, The Goldman Sachs Group reduced their price objective on Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating for the company in a research report on Wednesday, April 16th.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Kestra Medical Technologies stock. Brown Advisory Inc. purchased a new position in shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 550,418 shares of the company's stock, valued at approximately $13,716,000. Brown Advisory Inc. owned 1.07% of Kestra Medical Technologies as of its most recent filing with the Securities and Exchange Commission.

Kestra Medical Technologies Trading Down 1.8 %

Shares of KMTS traded down $0.44 during mid-day trading on Friday, hitting $24.06. The stock had a trading volume of 91,299 shares, compared to its average volume of 238,505. Kestra Medical Technologies has a fifty-two week low of $20.00 and a fifty-two week high of $26.15.

Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last issued its earnings results on Monday, April 14th. The company reported ($1.25) EPS for the quarter, missing the consensus estimate of ($0.64) by ($0.61). During the same period in the prior year, the business posted ($1.18) earnings per share.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.